文献速递精神分裂症与精神病性障碍

类视黄醇在精神分裂症中的作用:基因组与临床视角

The role of the retinoids in schizophrenia: genomic and clinical perspectives.
PubMed 文献 · Mol Psychiatry · 2019-10-30

本文综述类视黄醇生物学基础及类视黄醇系统失调参与精神分裂症病因的证据,涉及大规模基因组、转录组和蛋白质组研究,提示转运、代谢和信号传导等多方面异常,并提出新型药物和饮食干预的临床机会,但需进一步工作确认因果性。

要点

  • 类视黄醇信号对胚胎发育和人类大脑神经发生至关重要。
  • 大规模组学研究提示精神分裂症存在类视黄醇转运、代谢和信号传导异常。
  • 类视黄醇可能为精神分裂症提供新型药物和饮食干预机会,但因果性待确认。

核心结论

  • 大量文献证据支持类视黄醇系统失调参与精神分裂症病因。
  • 类视黄醇可能通过新型药物和饮食干预为精神分裂症提供临床机会。
  • 目前证据多为观察性数据,需进一步工作确认因果性。

研究设计与样本

  • 本文为综述,汇总大规模基因组、转录组和蛋白质组研究等证据。

主要发现

  • 类视黄醇是维生素A代谢物,可在全基因组范围影响数千转录本的表达。
  • 证据提示精神分裂症中类视黄醇转运、代谢和信号传导等不同方面存在异常。

临床怎么用

  • 类视黄醇可能作为精神分裂症新型药物和饮食干预的潜在靶点。

局限性

  • 现有数据多为观察性,需进一步工作确认因果性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Signalling by retinoid compounds is vital for embryonic development, with particular importance for neurogenesis in the human brain. Retinoids, metabolites of vitamin A, exert influence over the expression of thousands of transcripts genome wide, and thus, act as master regulators of many important biological processes. A significant body of evidence in the literature now supports dysregulation of the retinoid system as being involved in the aetiology of schizophrenia. This includes mechanistic insights from large-scale genomic, transcriptomic and, proteomic studies, which implicate disruption of disparate aspects of retinoid biology such as transport, metabolism, and signalling. As a result, retinoids may present a valuable clinical opportunity in schizophrenia via novel pharmacotherapies and dietary intervention. Further work, however, is required to expand on the largely observational data collected thus far and confirm causality. This review will highlight the fundamentals of retinoid biology and examine the evidence for retinoid dysregulation in schizophrenia.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Reay WR, Cairns MJ. The role of the retinoids in schizophrenia: genomic and clinical perspectives. Mol Psychiatry. 2019. PMID: 31666680. doi:10.1038/s41380-019-0566-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。